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Background/aim: Knee osteoarthritis (OA) is a common pathology characterized by degeneration of the articular cartilage. The aim of
the research was to ask patients how they decided to make the injection, what treatments they received, their complaints prior to and
after the injection and how they feel at the moment, and whether they are currently exercising or not. Thus, to demonstrate the patients’
outcomes with their own expression.
Materials and methods: A total of 92 knee OA patients completed semistructured interviews, which included six open-ended questions.
Results: A total of 92 patients (66 female, 26 male) aged between 36 and 95 years (mean 65.5±11.1) were included. Before the injection,
the majority of the OA patients had pain complaints when walking (72.8%) and ‘ascending stairs (70.7%). One to four years after
intraarticular injection, 45.2% of patients felt a decrease in their complaints. The majority of patients did not consider diet and exercise
as a treatment option. In addition, almost all patients declared that they decided on hyaluronic acid injection treatment with the
physician’s recommendation.
Conclusion: Pain during walking and ascending stairs before hyaluronic acid injection was common in knee-OA patients. Overall the
patients felt a decrease in the symptoms after injection. Patients did not consider diet and exercise as a treatment option despite the
recommendation by a physician.
Key words: Knee, osteoarthritis, qualitative study, injection, hyaluronic acid

1. Introduction
Progressive joint pain, deformity and limitation of
movement are common clinical findings of osteoarthritis
(OA) that may decrease the quality of life and may lead
to morbidity and mortality [1, 2]. The knee joint is the
most common site of OA among the peripheral joints and
is retained the second after the spine in the entire body
[3, 4]. Progression of OA can lead to total arthroplasty
of the knee joint [5]. The intraarticular injection of
hyaluronic acid (HA), also called viscosupplementation,
is a nonsurgical approach to the treatment of OA and
has become an increasingly popular treatment method in
recent years [6–8].
Several studies related to the knee OA have found
that HA injection is an effective and safe treatment for
improving the functional status and decreasing pain, along
with causing less significant side effects [7–10]. According
to a Cochrane review, HA injection has a therapeutic
benefit for pain during weight-bearing over placebo at 5
to 13 weeks postinjection [11]. On the other hand, other

metaanalysis showed no significant results involving pain
relief and functional improvement after the use of HA [12].
To better understand patients’ perception and outcome of
the knee function after the treatment, patient-reported
measures such as questionnaires are used widely in clinical
and research practice [13]. More recent metaanalysis on
this matter by Zhang et al. [14] found that platelet-rich
plasma (PRP) injections were more effective in reducing
pain than HA injections in knee OA patients at 6 and 12
months of follow-up assessed by the Western Ontario and
McMaster Universities arthritis index (WOMAC) pain
score questionnaire, whereas the visual analogue scales
(VAS) questionnaire showed no significant difference at
3 and 6 months. On the other hand, in a double-blind
randomized controlled trial of Cole et al., WOMAC
measures did not show a significant difference between
PRP and HA groups [15].
Different from this quantitative studies, the qualitative
study attempts to find the meaning of the case through
descriptions, experiences, and views of the participants
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[16]. Based on this, the researcher seeks to analyze the
subjects’ history regarding topic of interest in and deduce
in terms of meaningfulness and importance [17]. This
form of research allows participants to express their views
on their own terms. Mays and Pope [18] pointed out that
this type of interview is a flexible and powerful tool and
can open up new areas for research. Thus, the qualitative
method was deemed as a useful tool in the measurements
of the outcomes after HA injection, while it has a potential
to develop the uncovered field, due to the lack of qualitative
research in this area.
To our knowledge, patient-centered qualitative
evaluation of the success of HA knee injection is based on
very limited data. The aim of the research was, therefore,
to evaluate patients’ perceptions, outcomes, and sports
activity participation within 1–4 years after intraarticular
HA injection, as a treatment option for knee OA.
2. Patients and method
2.1. Design
This study was designed based on the principles and
methods of constructivist grounded theory [19].
Researchers’ goal was to obtain as much information as
possible from the patients’ own words, to understand beliefs
and actions from their perspectives and locate patients’
meanings within larger social structures and discussions
in explorative qualitative research designs [20]. Data were
obtained anonymously to ensure confidentiality.
2.2. Sampling and data collection
In this Turkish population-based qualitative designed
study, 92 patients aged 36–95 years (mean 65.5±11.1),
completed semistructured interviews. Included patients
were individuals ≥35 years presenting with knee pain
and (KL) grade 1–3 primary knee OA diagnosed
according to American College of Rheumatology (ACR)
classification Criteria. Thirty-one patients (34%) had KL
grade 1 OA, 32 (35%) grade 2, and 29 (31%) grade 3.
KL grade was determined by a physician experienced in
Kellgren–Lawrence (KL) radiographic classification of
knee osteoarthritis. Patients were free of any hearing or
speech impairment. Other inclusion criteria were: pain >
3 months, mean pain severity ≥2 on the numeric rating
scale (NRS), (K&L) grade I to III in medial and/or lateral
compartment as well. Patients with injuries of the knee,
also who had knee pain referred from the low back, KL
grade 4 OA, case with history of previous intraarticular
injection, severe hip OA, dermatologic knee disorders,
chondrocalcinosis, nonknee-related regular analgesic
use, inflammatory arthritis, allergy to HA components,
planned pregnancy or lactation, daily oral steroid therapy,
poor general health, conditions interfering with functional
assessments, alcoholism, malignancy, years, history of
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the knee surgery, along with psychiatric disorders and
dementia were excluded.
HA injections to participants were carried out every
week for 3 weeks. A semistructured interview with six
open-ended questions (Table 1) was developed by the
research team, which consisted of experienced clinicians, to
explore personal experiences and perspectives of patients
after HA injections. They were conducted with patients
within 1–4 years, 1st year as the earliest and 4th year as the
latest period, after intraarticular HA injections. Interviews
were conducted during routine outpatient clinic visits of
patients, and then written down by two interviewers. Each
interview with patients was audiotaped and transcribed
verbatim with the average length of the interviews about
50 min. In the literature, semistructured interview refers
to collect data by analyzing patient’s speech and its content
[18].
2.3. Analysis
Open coding, axial coding and developing a core
category that clarified the central matter of the data was
used for data analysis [19–21]. All written answers were
scanned and qualitative data analysis was conducted
with each transcript individually read line by line by two
researchers. Subsequent steps of the analysis consisted
of identification of the relevant texts, fragmentation of
the text in parts of meaning and developing code from
the obtained data. Qualitative responses were coded and
converted into quantified data by this method. These
results were afterwards discussed with the whole research
team regarding definitions and application of the codes to
ensure validity. To enhance the trustworthiness of the data,
an audit trail documenting the processes of data reduction
and analysis was maintained.
3. Results
A total of 92 patients (66 female, 26 male) aged between
36 and 95 years (mean 65.5±11.1) were included. When
patients were asked about their complaints prior to
injection, the majority of them responded that they had
complaints about the pain during walking (72.8%) and
ascending stairs (70.7%). Responses of other patients
were functional limitations (41.3%), waking up with
pain at night (18.5%), unable to sit on the knees (16.3%),
Table 1. Six open-ended questions.
1. What was your complaint prior to injection?
2. Which treatments were applied prior to the injection?
3. How did you decide to make an injection?
4. What did you feel during first 3 days after injection?
5. How do you feel yourself right now?
6. Did you return to exercise?
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crepitations (14.1%), knee locking (12%) and sensation
of “giving-way” (3.3%). A small minority of patients gave
as an answer pain in cold weather and while standing,
burning sensation, feeling of knee deformation and feeling
like a sharp piece of glass is cutting into the knee (Table 2).
In response to the second question, patients reported that
they had oral and/or topical NSAIDs (48.1%), physical
therapy modalities (40.5%), injection (36.7%), exercises
(15.2%), oral chondroprotective agents (11.4%) and other
treatments like cold bandage, cold pack and alternative
medicine (8.9%) (Table 2).
When the subjects were asked how they decided to
receive an intraarticular injection, it was shown that 90.2%
of patients decided to have an injection with the physician’s
recommendation, 15.2% of patients decided under the
influence of their friends and others and 3.3% of patients
decided because of their constant pain. According to the
patients, other reasons for intraarticular injection were
individual explorations such as a search on the Internet
and considering the injection as the last option before the
operation (6.5%) (Table 2).
56% of those surveyed reported that after intraarticular
injection, they felt no difference, where 25% of them
felt themselves more comfortable. Only 10.9% of the
respondents declared that their pain increased after the
HA injection, and 8.6% do not remember how they felt
during first 3 days after intraarticular injection (Table 2).
In order to obtain more information regarding side
effects after HA injections, the fourth question was
therefore extended. The majority of respondents (72%) felt
none of the following symptoms: joint warmth, pain, fever
or local erythema (Table 2).
One to four years after the intraarticular injection,
45.2% of patients felt a decrease in their complaints, 19.6%
of patients had no complaints at all, 17.4% of patients
did not feel any changes, whereas 17.4% of patients
are currently observed relapse after initial symptoms’
reduction, and the remaining 1.1% of patients whose
complaints have increased (Table 2).
After intraarticular injection, 40.9% of patients
resumed walking, 10.2% of patients resumed to homebased exercises and 9.1% of patients resumed to swimming
on a weekly basis, whereas 47.7% of patients did not return
any type of exercise.
4. Discussion
The most common form of arthritis, along with the fastest
growing reason of disability in the world, is OA [22]. About
18% of women and 9.6% of men over 60 years worldwide
experience a symptomatic OA, and 25% of them do not
perform everyday physical activities [23]. Intraarticular HA
injections have become an increasingly popular treatment
method in OA, in recent years due to their effectiveness

and safety issues [6–8]. To the best of our knowledge, this
is the first study with a qualitative evaluation of patients’
perception who previously underwent HA injection in the
knee joint.
The values of diseases are reflected in the personal
experience of people describing their conditions [24].
According to The American College of Rheumatology,
there are some key symptoms for osteoarthritis, including
morning stiffness lasting 30 min, crepitus on motion, bony
tenderness and bony enlargement [25]. Patients’ responses
in this study are in line with these criteria. In our study,
when the subjects were asked about their main complaints,
41.3% of them answered that they have functional
limitations and 14.1% have crepitations, along with 17.4%
of other complaints including bony enlargement. The
majority of the respondents declared that they experience
pain during walking (72.8%) and ascending the stairs
(70.7%).
Treatment options for OA are individualized for the
patients’ needs and preferences in order to provide highquality care for relieving these symptoms and improve
quality of life [26]. According to the guideline of OA
Research Society International (OARSI), that was published
in 2014 [27], land- and water-based exercises, strength
training, and weight management are the core treatments
applicable to all individuals. Along with the aforementioned,
additional pharmacological interventions can be advised,
structured on the characteristics of the individual patient.
When our patients were asked about treatments that were
applied prior to injection, 48.1% took (NSAIDs) and 40.5%
proceeded to physical therapy. In a metaanalysis of Bannuru
et al. [28], where the data regarding the efficacy of HA in
comparison with nonsteroidal antiinflammatory drugs
(NSAIDs) for knee OA was obtained, declared that there
was no significant difference between HA and NSAIDs in
continuous follow-up at 4 and 12 weeks. However, given
the more favorable safety in favor of HA over NSAIDs, the
authors stated that HA might be an alternative to NSAIDs
for knee OA, especially for elderly patients with a high risk
of systemic side effects. More recent pieces of evidence
suggest that various forms of exercise have positive
effects on pain and joint function for OA patients [29,30].
However, only 9.4% of those surveyed reported that
exercise program was recommended as a treatment in our
study. These findings are consistent with previous reports
on low-rate recommendation of exercise, noncompliance
to exercise therapy and lifestyle counseling, and warrant
further investigation to increase this low level of adherence
[31,32]. The most appropriate knee OA management,
including exercise therapy, should be designed according
to a patient-centered approach.
When patients are facing serious illnesses, which
can cause changes in body image and lifestyle activity, it
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Table 2. Answers of the participants to open-ended questions.
N = 92
1.

2.

3.

4.

5.

6.

N*

%

Pain during walking

67

72.8

Pain during ascending the stairs/hill

65

70.7

Functional limitations

38

41.3

Waking up with pain at the night

17

18.5

Unable to sit on the knees

15

16.3

Crepitations

13

14.1

Knee locking

11

12

Sensation of “giving away”

3

3.3

Other

16

17.4

Oral/topical NSAIDs

38

48.1

Physical therapy

32

40.5

Injection

29

36.7

Exercise

12

15.2

Oral chondroprotective agents

9

11.4

Other

7

8.9

Physician’s recommendation

83

90.2

Friend/community

14

15.2

Complains

3

3.3

Other

6

6.5

What was your complaint prior to injection?

Which treatments were applied prior to injection?

How did you decide to make an injection?

What did you feel during first 3 days after injection?
Did not feel any difference

52

56.5

Felt more comfortable

23

25

Pain increased

10

10.9

Do not remember

8

8.6

Complaints decreased

42

45.6

Do not have any complaints

18

19.5

Complaints remained unchanged

16

17.4

At the beginning complains decreased/gone, but now recrudescence in complaints

16

17.4

Complaints increased

1

1.1

None

42

47.7

Walking

36

40.9

Home exercises

9

10.2

Swimming

8

9.1

Running

3

3.4

How do you feel yourself right now?

Did you return to the exercise?

*Valid response category percentages > 100% because each response could contain more than one coded unit.
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is important to understand what influenced the patients
regarding the decision-making process in treatment
options. When the subjects were asked what influenced
their decision to undergo HA injection of the knee joint,
90.2% said that the decision to choose a treatment option
was proposed on the recommendation of the doctor. This
result is in conformity with previous studies, showing
the role of physician on decision making process [33]. It
has been reported that HA is most frequently prescribed
by physicians to patients with early-stage (82%) or midstage (82.8%) OA [34]. To our knowledge, this is the
first qualitative designed paper addressing the role of
clinician’s in choosing the use of HA for the treatment of
knee OA. It is important to note that physicians have a
potential influence regarding treatment recommendations
that influence the choice of patients.
The recommendations of the European League against
Rheumatism (EULAR) show that there is evidence to
support the effectiveness of HA in accordance with the
level 1B indications for both pain reduction and joint
functional improvement of the knee joint [35]. However,
the expected effect can be obtained within a few months,
rather than within a few weeks, as with the use of a
steroid. Patients’ responses regarding their well-being
during first 3 days after intra-articular injection, 56.5%
of those surveyed reported no difference, where 25% of
them felt themselves more comfortable. Only 10.9% of
the respondents declared that their pain increased after
the HA injection and 8.6% don’t remember how they felt
during first 3 days after intraarticular injection.
In order to get more information regarding side effects
after HA injections, the aforementioned question was
therefore extended and the 71% of respondents felt none
of the following symptoms: joint warmth, pain, fever or
local erythema. These results were similar to a systematic
review and metaanalysis of Millers et al.[36], where the
safety and efficacy of US-approved HA knee injections
were randomized with saline controls, found no statistical
difference regarding serious adverse effects between these
two groups in patients with knee OA. Some adverse
effects such as increased rate of flare [37], granulomatous
inflammation [38] and a few local infections (like septic
arthritis) have also been reported. A recent systematic
review found no difference in the side effect rate between
single injections of HA and placebo [39]. In our study,
21.7% of patients felt pain, fever or erythema, and none
of our patients described any serious adverse effects like
septic arthritis. The Cochrane review of 2014 showed that
viscosupplementation for the knee OA provides pain relief
and improved physical function with a low risk of harm
[40].
Many researchers have studied the efficacy of HA
injection in the treatment of the knee OA in long-term.
According to the recent analysis of US-approved HA

injections showed a better treatment effect compared to
preinjection values from 4 weeks to 26 weeks for pain
and knee function, in comparison with placebo [36]. In
the study of Miltner et al.[41], where patients underwent
HA injection, showed improvement at VAS and maximum
peak-torque. In 2010, Chevalier et al.[42], stated that a
single 6-mL intraarticular injection of Hylan G-F 20 was
safe and effective in providing statistically significant and
clinically relevant pain relief over 26 weeks, with a modest
difference versus placebo. Our study is in line to these
studies, where we found that 45.6% of patients felt the
decrease in their complaints, 19.5% of patients currently
do not have any complaints, and 17.4% of patients had
at the beginning complaints decreased and even gone,
but now recrudescence in complaints. DeCaria et al.[43]
reported no difference in gait velocity compared with
placebo, but they found that patients treated with HA had
improvements in WOMAC scores for pain, stiffness, and
physical function.
Our study has several limitations including,
prominently, the fact that the respondents were patients of
the same hospital, and hence the results cannot be applied
to the general population. Therefore, future studies with a
larger sample with knee OA should be recruited. Secondly,
there were difficulties in translating the patients’ interviews
from Turkish to English in the concept of research
results, even though the translation was performed by a
professional translator who did not interview the subjects
in this study. In consequence, the researchers repeatedly
discussed the accuracy of the translation, so that the basic
concepts were not lost in the translation. Therefore, future
studies are needed to overcome these issues.
In conclusion, we would like to mention that despite
all the limitations, this research, to our best knowledge is
the first qualitative study regarding outcomes before and
after HA injection. Our study identified main complaints
of the patients before injection, which were following,
the pain when walking and ascending stairs. Most of the
patients underwent treatments prior to HA injections;
however, many patients didn’t consider diet and exercises
as a treatment option. Along with the aforementioned, our
findings showed that choosing HA as a treatment option
was proposed on the recommendation of the doctor.
Therefore, physicians should improve their relationship
with the patient by providing adapted and formalized
information to patients regarding the efficacy of treatment
strategies, adapting more approved guidelines and
therapeutic approaches, which are the main factors of
symptoms’ improvement in OA.
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